On Friday, the Fifth Circuit Court of Appeals issued a unanimous ruling that reverses existing FDA policy and prevents the mailing of chemical abortion drugs. As recently as 2021, women seeking chemical abortions had to have at least one in-person meeting with a medical professional. However, during the Covid-19 pandemic, the FDA liberalized its policy. An in-person meeting with a health professional was no longer required and women could obtain chemical abortion pills through the mail. Both the Biden administration FDA and the Trump administration FDA have continued this policy after the Covid-19 pandemic’s conclusion.

Since chemical abortion drugs can be mailed into pro-life states, these telehealth abortions undermine the strong pro-life laws that many states have enacted since the Supreme Court’s Dobbs decision. As such, in recent years,........

© National Review